Pricing database updated August 4, 2026Methodology v1.0How we score →
Compare Providers
Home / Pharmacy-verification methodology
Written by Dr. Parmis Mojarab, DO·Published July 12, 2026·Last reviewed August 4, 2026·Methodology v1.0
This page is maintained. Prices are re-read at source and dated; evidence is checked against the published trial. Newest across the site: news · research · corrections.

Pharmacy-verification methodology

How we verify the pharmacies behind telehealth GLP-1 and peptide programs.

Verification steps

We confirm the pharmacy is named, check its state license (503A) or FDA registration (503B), verify the prescribing clinician is named, and confirm disclosed concentration and formulation. Unnamed pharmacy equals a failed check.

What we record

Pharmacy name, 503A/503B status, license jurisdictions, FDA registration where applicable, provider relationships, verification URL and date.

How the dates on this page work. Manufacturer self-pay prices — NovoCare and LillyDirect — were re-read on the manufacturers’ own published price guides on 4 August 2026. Figures captured from third-party provider websites carry the date we read that provider’s page, which may be earlier; where it is, the row says so. We do not restamp a figure we have not re-read.